About the Mounjaro Injection: a plain guide to how it works

Mounjaro is the only dual GIP and GLP-1 receptor agonist licensed for weight management in the UK, a different mechanism from singleagonist treatments.
Each KwikPen delivers a once-weekly subcutaneous injection; a single pen holds four doses and is used at home after brief initial guidance.
Treatment begins at 2.5 mg to let your body adjust; a prescriber then reviews your progress before any dose change.
Common side effects are mainly gastrointestinal, tend to be most noticeable early on, and usually settle within the first couple of weeks at each dose.

The Mounjaro injection is a once-weekly subcutaneous injection of tirzepatide, a prescription medicine licensed in the UK for weight management in adults. It comes as a pre-filled KwikPen — each pen contains four weekly doses — and works by activating two gut-hormone receptors simultaneously to reduce appetite and slow gastric emptying. As a prescription-only medicine, it can only be obtained following a clinical assessment by a qualified prescriber, who will decide whether it is appropriate for you personally. The sections below walk through exactly what the injection is, how to use it step by step, which side effects to watch for, and who the treatment is licensed for.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using the Mounjaro injection in practice: what each step looks like

Step 1, Getting the prescription and your first pen

Before the pen is in your hands, a prescriber has to conclude it is right for you. That assessment covers your BMI, your health history, any medicines you take, and whether a weight-related condition raises your clinical need. The licensed eligibility is a BMI of 30 or above, or 27 or above alongside at least one condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance.

One thing worth gently setting aside: a lot of people assume the injection itself is the complicated part. In practice, the clinical decision that precedes it is the part that takes real care. The KwikPen is designed to be straightforward for self-administration at home, and if you are considering the Synedica tirzepatide pen as an alternative device option, that page covers how it compares. If you are curious about what the pen looks like before committing to a consultation, the overview of Mounjaro injection pens covers the device in detail.

Once a prescriber at a GPhC-registered pharmacy is satisfied, a prescription is issued, the pen is dispensed, and you receive the Patient Information Leaflet that accompanies every pack. That leaflet is the primary reference for the exact steps that follow, reading it before your first injection is not a formality, it is genuinely useful.

Step 2, Preparing and giving the injection

Mounjaro is injected once weekly, on the same day each week where possible, into the fatty tissue just beneath the skin. The three approved sites are the abdomen, the outer thigh, and the upper arm. Rotating between sites matters, using the same spot repeatedly can affect how the medicine is absorbed and may cause skin reactions. A practical guide to rotating correctly is in our injection site guide.

Before injecting, wash your hands. If you are using an alcohol swab to clean the skin first, let it dry fully before pressing the pen to the site, damp skin makes the process less comfortable. For a full walkthrough of the administration process, our guide to the Mounjaro injection covers each step in detail, including what to do if something feels uncertain the first time. The KwikPen clicks when pressed against the skin and held in place; you hold it there until the injection is complete, which the pen signals. Needles should be changed with every injection. A pack of compatible needles makes it straightforward to keep a supply at home.

Used needles and pens count as sharps waste and cannot go into household recycling. Your local pharmacy or GP surgery can advise on disposal, and a sharps container keeps them safe between collections. Storage is in the fridge at 2–8°C; for the precise room-temperature window permitted before use, consult the Patient Information Leaflet or the Mounjaro SmPC on the eMC, that window does vary by circumstance and should not be guessed.

Step 3, What to expect in the early weeks

The 2.5 mg starting dose has one job: letting your body acclimatise. It is not the dose at which most people experience meaningful weight loss; the prescriber will review your progress and tolerance before any change. This staged approach is why the titration schedule exists, rushing through it increases the chance of side effects without adding benefit.

Those side effects are mainly gastrointestinal. Nausea is the most commonly reported, alongside looser stools, constipation in some people, indigestion, and occasional burping. They are most pronounced in the first few days after a new dose, and most people find they settle considerably within a couple of weeks. Eating smaller portions, avoiding very fatty or spicy meals, and staying well hydrated all help. Fatigue and mild headaches are also reported, particularly early on.

Two symptoms need prompt medical attention rather than watchful waiting: severe stomach pain that spreads towards the back (a possible sign of pancreatitis, flagged in the MHRA's January 2026 Drug Safety Update on GLP-1 medicines), and any signs of a serious allergic reaction such as swelling or breathing difficulty. The NHS patient information page on tirzepatide lists the full range of side effects and the thresholds for seeking help. If you notice something unexpected and are unsure, the Yellow Card scheme at yellowcard.mhra.gov.uk allows patients to report suspected reactions directly to the MHRA.

The broader picture: cost, travel, and ongoing clinical oversight

Using Mounjaro at home week after week is routine quickly. A few practical points are worth knowing before you start. If you plan to travel, the pen needs to stay refrigerated, and some travel insurance policies ask about prescription medicines, it is worth understanding the implications for travel insurance before you fly. And if you ever want to understand how private Mounjaro pricing is structured across providers, the Mounjaro price comparison page gives a factual, jargon-free breakdown of what drives the cost difference between services.

Ongoing clinical oversight matters as much as the injection technique. Every repeat prescription should involve a review of your progress, not just a rubber-stamp. That is why, at nume, a real prescriber reads your update before each repeat, and the clinical team page explains who is doing that review. Treatment is one part of the picture; the lifestyle changes that support it are the other.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions